Neoplasms by Site Not Yet Recruiting Phase 2 Trials for Anlotinib (DB11885)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030096 (Neoplasms by Site) | Not Yet Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04807166 | Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer | Treatment |